|Th17 cells in cancer: the ultimate identity crisis|
SR Bailey, MH Nelson, RA Himes, Z Li, S Mehrotra, CM Paulos
Frontiers in immunology 5, 276, 2014
|CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity|
BD Choi, X Yu, AP Castano, AA Bouffard, A Schmidts, RC Larson, ...
Nature biotechnology 37 (9), 1049-1058, 2019
|When worlds collide: Th17 and Treg cells in cancer and autoimmunity|
HM Knochelmann, CJ Dwyer, SR Bailey, SM Amaya, DM Elston, ...
Cellular & molecular immunology 15 (5), 458-469, 2018
|CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma|
BD Choi, X Yu, AP Castano, H Darr, DB Henderson, AA Bouffard, ...
Journal for immunotherapy of cancer 7 (1), 1-8, 2019
|Gene editing for immune cell therapies|
SR Bailey, MV Maus
Nature biotechnology 37 (12), 1425-1434, 2019
|PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells|
JS Bowers, K Majchrzak, MH Nelson, BA Aksoy, MM Wyatt, AS Smith, ...
Frontiers in immunology 8, 1221, 2017
|Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence|
SR Bailey, MH Nelson, K Majchrzak, JS Bowers, MM Wyatt, AS Smith, ...
Nature communications 8 (1), 1961, 2017
|CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours|
RC Larson, MC Kann, SR Bailey, NJ Haradhvala, PM Llopis, AA Bouffard, ...
Nature 604 (7906), 563-570, 2022
|Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of TumorsCD73 Expression Dampens Antitumor Th17 Response|
S Chatterjee, K Thyagarajan, P Kesarwani, JH Song, M Soloshchenko, ...
Cancer research 74 (21), 6048-6059, 2014
|Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion|
JS Bowers, MH Nelson, K Majchrzak, SR Bailey, B Rohrer, ADM Kaiser, ...
JCI insight 2 (5), 2017
|Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19CAR T Cells Targeting CD79b|
M Ormhøj, I Scarfò, ML Cabral, SR Bailey, SJ Lorrey, AA Bouffard, ...
Clinical Cancer Research 25 (23), 7046-7057, 2019
|The basics of artificial antigen presenting cells in T cell-based cancer immunotherapies|
LR Neal, SR Bailey, MM Wyatt, JS Bowers, K Majchrzak, MH Nelson, ...
Journal of immunology research and therapy 2 (1), 68, 2017
|β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity|
K Majchrzak, MH Nelson, JS Bowers, SR Bailey, MM Wyatt, JM Wrangle, ...
JCI insight 2 (8), 2017
|Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic|
K Majchrzak, MH Nelson, SR Bailey, JS Bowers, XZ Yu, MP Rubinstein, ...
Cancer Immunology, Immunotherapy 65, 247-259, 2016
|Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 SignalingTBI-Induced IL12 Augments …|
JS Bowers, MH Nelson, S Kundimi, SR Bailey, LW Huff, KM Schwartz, ...
Clinical Cancer Research 21 (11), 2546-2557, 2015
|Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning|
MH Nelson, JS Bowers, SR Bailey, MA Diven, CW Fugle, ADM Kaiser, ...
Journal for immunotherapy of cancer 4 (1), 1-14, 2016
|Blockade or deletion of IFNγ reduces macrophage activation without compromising CAR T-cell function in hematologic malignancies|
SR Bailey, S Vatsa, RC Larson, AA Bouffard, I Scarfò, MC Kann, ...
Blood Cancer Discovery 3 (2), 136-153, 2022
|Identification of human CD4+ T cell populations with distinct antitumor activity|
MH Nelson, HM Knochelmann, SR Bailey, LW Huff, JS Bowers, ...
Science advances 6 (27), eaba7443, 2020
|Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia|
MB Leick, H Silva, I Scarfò, R Larson, BD Choi, AA Bouffard, K Gallagher, ...
Cancer Cell 40 (5), 494-508. e5, 2022
|Targeted complement inhibition protects vascularized composite allografts from acute graft injury and prolongs graft survival when combined with subtherapeutic cyclosporine a …|
P Zhu, SR Bailey, B Lei, CM Paulos, C Atkinson, S Tomlinson
Transplantation 101 (4), e75, 2017